Conley, B A <br/><br/>
Salivary concentrations of hexamethylene bisacetamide (HMBA) in patients receiving 5-day continuous infusions.  [electronic resource] 

 -  Cancer chemotherapy and pharmacology  1988 
 - 65-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0344-5704 
<br/><br/><label>Standard No.: </label>10.1007/BF00254184  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acetamides--administration & dosage<br/>Dose-Response Relationship, Drug<br/>Drug Administration Schedule<br/>Humans<br/>Infusions, Intravenous<br/>Saliva--analysis<br/>Time Factors